(Q33330188)
Statements
1 reference
Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin, and cyclophosphamide in stage II and III breast cancer (English)
1 reference
S E Jones
1 reference
P Khandelwal
1 reference
K McIntyre
1 reference
R Mennel
1 reference
D Orr
1 reference
R Kirby
1 reference
E Agura
1 reference
L Duncan
1 reference
W Hyman
1 reference
T Roque
1 reference
D Regan
1 reference
M Schuster
1 reference
N Dimitrov
1 reference
L Garrison
1 reference
M Lange
1 reference
1 October 1999
1 reference
1 reference
17
1 reference
10
1 reference
3025-3032
1 reference
Identifiers
1 reference
1 reference